These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9158104)

  • 1. IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese diabetic (NOD) mice.
    Sandberg JO; Eizirik DL; Sandler S
    Clin Exp Immunol; 1997 May; 108(2):314-7. PubMed ID: 9158104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
    Saldeen J; Sandler S; Bendtzen K; Welsh N
    Cytokine; 2000 Apr; 12(4):405-8. PubMed ID: 10805224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy.
    Wang T; Singh B; Warnock GL; Rajotte RV
    Diabetes; 1992 Jan; 41(1):114-7. PubMed ID: 1727730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival.
    Sandberg JO; Eizirik DL; Sandler S; Tracey DE; Andersson A
    Diabetes; 1993 Dec; 42(12):1845-51. PubMed ID: 8243831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
    Gysemans C; Stoffels K; Giulietti A; Overbergh L; Waer M; Lannoo M; Feige U; Mathieu C
    Diabetologia; 2003 Aug; 46(8):1115-23. PubMed ID: 12879250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of IL-1 trap prolongs survival of transplanted pancreatic islets to type 1 diabetic NOD mice.
    Rydgren T; Öster E; Sandberg M; Sandler S
    Cytokine; 2013 Aug; 63(2):123-9. PubMed ID: 23664771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effect on syngeneic islet transplantation by transgenic coexpression of decoy receptor 3 and heme oxygenase-1 in the islet of NOD mice.
    Huang SH; Lin GJ; Chien MW; Chu CH; Yu JC; Chen TW; Hueng DY; Liu YL; Sytwu HK
    Transplant Proc; 2013 Mar; 45(2):580-4. PubMed ID: 23267792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor immune cells in pancreatic islet transplantation.
    Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
    Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
    Suarez-Pinzon WL; Rabinovitch A
    Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist prevents low dose streptozotocin induced diabetes in mice.
    Sandberg JO; Andersson A; Eizirik DL; Sandler S
    Biochem Biophys Res Commun; 1994 Jul; 202(1):543-8. PubMed ID: 8037760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
    Kimura T; Ito A; Hancock WW; Maki T
    J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
    Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
    Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes.
    Utsugi T; Nagata M; Kawamura T; Yoon JW
    Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.